Climb Bio, Inc. Share Price
NASDAQ: CLYM | Small CapClimb Bio, Inc. Stock Performance
Open $14.84 | Prev. Close $15.10 | Circuit Range N/A |
Day Range $14.50 - $15.12 | Year Range $1.54 - $18.32 | Volume 45,543 |
Average Traded $14.85 |
Climb Bio, Inc. Share Price Today
As of 30 August 2026, Climb Bio, Inc.'s share price is $14.57. The stock opened at $14.84, compared to its previous close of $15.10. During today's trading session, Climb Bio, Inc.'s share price traded between $14.50 and $15.12, with an average price of $14.81. Over the past 52 weeks, the stock has recorded a high of $18.32 and a low of $1.54. In terms of performance, Climb Bio, Inc.'s share price has risen by 102.92% over the last six months and is up 549.00% on a year-on-year basis.
Climb Bio, Inc. Share Price Chart
Climb Bio, Inc. Stock Fundamentals & Key Indicators
Market Cap $988.02M | PE Ratio (TTM) -16.56 | Dividend Yield N/A |
EPS (TTM) $-0.88 | Revenue (TTM) N/A | Return On Equity (TTM) -37.30% |
Profit Margin N/A | Debt to Equity 0.04 | Quarterly Earnings Growth YoY -44.89% |
Climb Bio, Inc. Quarterly Profit & Loss
All figures in USD
Climb Bio, Inc. Annual Profit & Loss
All figures in USD
About Climb Bio, Inc.
Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases. The company develops budoprutug, an anti-CD19 monoclonal antibody for the treatment of B-cell mediated diseases. It is also developing budoprutug IV for the treatment of primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus. In addition, the company is developing CLYM116, a preclinical stage anti A Proliferation-inducing Ligand (APRIL) monoclonal antibody for the treatment of immunoglobin A nephropathy (IgAN). The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wellesley Hills, Massachusetts.
Climb Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $11.67 | $15.06 | +26.54% |
Jul 2026 | $12.98 | $11.90 | -8.77% |
Jun 2026 | $10.94 | $13.05 | +19.18% |
May 2026 | $8.61 | $10.95 | +23.45% |
Apr 2026 | $7.10 | $8.87 | +29.49% |
Mar 2026 | $6.79 | $6.85 | -4.60% |
Feb 2026 | $4.50 | $7.18 | +60.63% |
Jan 2026 | $4.10 | $4.47 | +11.75% |
Dec 2025 | $1.86 | $4.00 | +112.77% |
Nov 2025 | $2.06 | $1.88 | -7.84% |
Oct 2025 | $1.99 | $2.04 | +1.54% |
Sep 2025 | $2.20 | $2.01 | -10.51% |
CLYM Share Price FAQs
What is Climb Bio, Inc. share price today?
What is the 52 week high and 52 week low of Climb Bio, Inc. stock?
What is CLYM's market capitalisation today?
What is CLYM's net income for the last quarter?
What is the 5 year returns of CLYM?
What is the high & low stock price of CLYM today?
Can I buy CLYM shares in India?